tiprankstipranks
Trending News
More News >
Loblaw Companies (TSE:L)
TSX:L
Advertisement

Loblaw Companies (L) AI Stock Analysis

Compare
934 Followers

Top Page

TSE:L

Loblaw Companies

(TSX:L)

Select Model
Select Model
Select Model
Outperform 80 (OpenAI - 4o)
Rating:80Outperform
Price Target:
C$65.00
â–²(5.03% Upside)
Loblaw Companies' strong financial performance and positive earnings call are the most significant factors driving the stock score. While technical analysis and valuation are more moderate, the company's strategic initiatives and growth potential support a favorable outlook.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term financial stability.
Online Sales Expansion
Significant growth in online sales enhances Loblaw's multi-channel strategy, catering to evolving consumer preferences and increasing market reach.
Strategic Partnership
The partnership with Uber Eats expands Loblaw's distribution channels, potentially increasing customer base and sales through enhanced convenience.
Negative Factors
Rising Debt Levels
Moderate leverage requires careful management to avoid financial strain, potentially impacting long-term investment and growth capacity.
Optical Business Exit
The exit from the optical business incurs costs and may temporarily impact sales, reflecting challenges in segment management and strategic adjustments.
Segment Challenges
Challenges in specific segments like liquor and tobacco can hinder overall sales growth, requiring strategic focus to mitigate impacts.

Loblaw Companies (L) vs. iShares MSCI Canada ETF (EWC)

Loblaw Companies Business Overview & Revenue Model

Company DescriptionLoblaw Companies Limited is one of Canada's largest food retailers, operating a diverse range of grocery stores, pharmacy services, and other retail offerings. The company is known for its flagship supermarket chain, Loblaws, as well as Shoppers Drug Mart, and it serves millions of customers across the country. Loblaw operates in various sectors, including food retail, pharmacy, and apparel, providing a wide array of products ranging from groceries and fresh produce to health and wellness items.
How the Company Makes MoneyLoblaw Companies generates revenue primarily through the sale of groceries and pharmacy products. Its revenue model includes income from retail sales at its supermarkets and drugstores, where it offers a variety of food, health, and beauty items. Additionally, Loblaw earns revenue from its private label brands, which tend to have higher margins compared to national brands. The company also generates income through its loyalty program, PC Optimum, which encourages customer retention and repeat purchases. Significant partnerships with suppliers and manufacturers enable Loblaw to negotiate favorable terms and optimize its product offerings. Furthermore, the company benefits from economies of scale due to its extensive network of stores, which enhances its purchasing power and operational efficiency.

Loblaw Companies Earnings Call Summary

Earnings Call Date:Nov 12, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 19, 2026
Earnings Call Sentiment Positive
The earnings call presented a generally positive outlook, with significant revenue growth, market share gains, and strong performance in drug retail and online sales. However, there were challenges in specific segments like liquor and optical business, leading to some negative impacts on sales. Overall, the positive aspects significantly outweighed the lowlights, indicating a strong performance and optimistic future outlook.
Q3-2025 Updates
Positive Updates
Consistent Financial and Operational Performance
Loblaws Inc. reported consolidated revenue growth of 4.6%, reaching $19.4 billion, with adjusted EBITDA increasing by 7.2% to $2.2 billion. Adjusted diluted net earnings per share grew by 11.3% to $0.69.
Retail Expansion and Market Share Gains
76 new stores opened over the past 12 months, increasing retail square footage by 2%. The company reported significant tonnage market share gains in food retail, with food sales growing 4.8%.
Strong Drug Retail Performance
Drug retail business grew by 3.8%, with same-store sales increasing by 4%. Pharmacy and health care services grew by 5.9%, driven by prescription strength and new health care services.
Online Sales Growth
Online sales increased by 18% across retail businesses, with delivery leading growth in the online grocery channel.
Positive Outlook for Q4 and Beyond
The company expects full-year adjusted EPS growth to increase slightly from high single digits into the low double digits, excluding the impact of the 53rd week.
Negative Updates
Challenges in Certain Segments
Headwinds from liquor, specifically in tobacco, and the exit from the optical business led to a net 30 basis point negative impact on same-store sales.
Impact of Optical Business Exit
Exiting the Theodore and Pringle optical business resulted in a $30 million adjusted charge for the quarter and is expected to negatively impact food same-store sales by approximately 20 basis points until the transaction is lapped.
Company Guidance
During the Loblaws Inc. Third Quarter 2025 Results Conference Call, the company outlined strong financial performance and strategic initiatives. Revenue for the quarter grew by 4.6% to $19.4 billion, with the drug retail business increasing by 3.8% and food retail by 4.8%. Adjusted EBITDA rose 7.2% to $2.2 billion, improving the margin by 20 basis points to 11.4%. Adjusted diluted net earnings per share increased by 11.3% to $0.69, while GAAP net earnings per share grew by 4.8%. The company saw a 2% increase in food same-store sales and a 4% increase in drug retail same-store sales. Online sales surged by 18%, driven by strong growth in the online grocery channel. Loblaw's internal food inflation was lower than Canada's grocery CPI of 3.6%, indicating increased value for Canadian shoppers. The company opened 76 stores over the past 12 months, expanding retail square footage by 2%. They also announced a partnership with Specsavers to open 111 locations, replacing the Theodore and Pringle optical business, which resulted in a $30 million adjusted charge this quarter. Looking forward, Loblaw expects full-year adjusted EPS growth to edge into low double digits, excluding the 53rd week impact.

Loblaw Companies Financial Statement Overview

Summary
Loblaw Companies demonstrates strong financial performance with consistent revenue growth, solid profitability, and efficient cash flow generation. The company maintains healthy margins and returns on equity, although moderate leverage requires careful management.
Income Statement
85
Very Positive
Loblaw Companies has demonstrated consistent revenue growth, with a TTM revenue growth rate of 1.18%. The company maintains strong profitability with a gross profit margin of 32.29% and a net profit margin of 3.96%. EBIT and EBITDA margins are also healthy at 6.97% and 11.63%, respectively, indicating efficient operations. The steady improvement in margins over the years reflects effective cost management and operational efficiency.
Balance Sheet
78
Positive
The company's debt-to-equity ratio stands at 1.77, indicating a moderate level of leverage. Return on equity is robust at 22.23%, showcasing effective utilization of shareholder funds to generate profits. The equity ratio is stable, reflecting a balanced capital structure. However, the increasing debt levels over the years could pose potential risks if not managed carefully.
Cash Flow
82
Very Positive
Loblaw Companies exhibits strong cash flow generation with a TTM free cash flow growth rate of 3.82%. The operating cash flow to net income ratio of 0.54 and free cash flow to net income ratio of 0.66 indicate solid cash conversion efficiency. The consistent growth in free cash flow over the years highlights the company's ability to generate cash to support operations and growth initiatives.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue62.29B61.01B59.53B56.50B53.17B52.71B
Gross Profit20.11B19.73B19.04B17.98B16.73B15.99B
EBITDA7.26B6.90B6.64B6.17B5.80B4.96B
Net Income2.47B2.17B2.10B1.92B1.88B1.11B
Balance Sheet
Total Assets40.45B40.88B38.98B38.15B36.61B35.87B
Cash, Cash Equivalents and Short-Term Investments1.90B2.11B1.95B1.93B2.44B1.94B
Total Debt19.52B19.18B18.17B17.61B16.55B16.61B
Total Liabilities29.25B29.61B27.36B26.69B24.88B24.75B
Stockholders Equity11.03B11.09B11.46B11.30B11.57B10.99B
Cash Flow
Free Cash Flow3.89B3.60B3.58B3.18B3.65B4.03B
Operating Cash Flow5.86B5.80B5.65B4.75B4.83B5.19B
Investing Cash Flow-2.04B-2.02B-1.84B-2.37B-1.27B-1.38B
Financing Cash Flow-4.15B-3.82B-3.93B-2.75B-3.25B-3.28B

Loblaw Companies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price61.89
Price Trends
50DMA
56.72
Positive
100DMA
56.43
Positive
200DMA
54.01
Positive
Market Momentum
MACD
1.54
Negative
RSI
65.99
Neutral
STOCH
92.29
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:L, the sentiment is Positive. The current price of 61.89 is above the 20-day moving average (MA) of 58.36, above the 50-day MA of 56.72, and above the 200-day MA of 54.01, indicating a bullish trend. The MACD of 1.54 indicates Negative momentum. The RSI at 65.99 is Neutral, neither overbought nor oversold. The STOCH value of 92.29 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:L.

Loblaw Companies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$72.44B29.3221.51%1.49%4.21%14.03%
78
Outperform
C$20.12B20.2314.48%1.50%3.71%12.40%
72
Outperform
C$33.11B32.9526.36%1.21%4.15%149.50%
70
Outperform
C$11.24B16.3012.97%1.64%1.96%9.26%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
C$2.19B15.8218.55%3.33%3.04%4.17%
61
Neutral
C$13.83B-95.78-1.32%1.99%5.37%-135.85%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:L
Loblaw Companies
61.89
17.17
38.39%
TSE:EMP.A
Empire Co Cl A NV
52.35
11.05
26.76%
TSE:MRU
Metro Inc.
100.14
9.30
10.24%
TSE:NWC
North West
49.00
-1.12
-2.23%
TSE:SAP
Saputo Inc.
38.70
13.15
51.47%
TSE:WN
George Weston
94.70
21.65
29.64%

Loblaw Companies Corporate Events

Business Operations and StrategyFinancial DisclosuresStock Split
Loblaw Companies Reports Strong Q3 Revenue Growth and Strategic Expansion
Positive
Nov 12, 2025

Loblaw Companies reported a 4.6% revenue growth in the third quarter of 2025, driven by increased customer engagement and new store openings. The company’s focus on value offerings and loyalty rewards contributed to higher sales in both food and drug retail segments. Loblaw’s strategic expansion includes opening 76 new stores and 100 new pharmacy clinics by the end of the year, enhancing its market presence and providing affordable groceries and healthcare to underserved communities across Canada. The company also completed a four-for-one stock split, reflecting its strong financial performance and commitment to future growth.

The most recent analyst rating on (TSE:L) stock is a Buy with a C$67.00 price target. To see the full list of analyst forecasts on Loblaw Companies stock, see the TSE:L Stock Forecast page.

Business Operations and StrategyStock Split
Loblaw Completes Four-For-One Stock Split
Positive
Aug 19, 2025

Loblaw Companies Limited has completed a four-for-one stock split of its common shares, effective as of August 19, 2025. This move, executed through a stock dividend, is expected to enhance the liquidity of Loblaw’s shares and potentially broaden its investor base, reflecting the company’s strategic efforts to strengthen its market position.

The most recent analyst rating on (TSE:L) stock is a Buy with a C$261.00 price target. To see the full list of analyst forecasts on Loblaw Companies stock, see the TSE:L Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 13, 2025